Knoll Capital Management, LLC Soligenix, Inc. Transaction History

Knoll Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.51 - $117.79 $120,775 - $27.9 Million	-236,814 Reduced 87.2%	34,766 $15,000
Q1 2022 May 16, 2022	SELL	$0.61 - $0.75 $100,650 - $123,750	-165,000 Reduced 37.79%	271,580 $198,000
Q4 2021 Feb 14, 2022	SELL	$0.66 - $1.1 $231,825 - $386,375	-351,250 Reduced 44.58%	436,580 $288,000
Q3 2019 Nov 14, 2019	SELL	$0.72 - $1.31 $35,978 - $65,460	-49,970 Reduced 5.96%	787,830 $748,000
Q1 2018 May 15, 2018	SELL	$1.92 - $2.4 $61,824 - $77,280	-32,200 Reduced 3.7%	837,800 $1.64 Million
Q4 2017 Feb 14, 2018	BUY	$1.84 - $2.32 $1.6 Million - $2.02 Million	870,000	870,000 $1.84 Million

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $125M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Knoll Capital Management, LLC with notifications on news.